Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Soft tissue injury

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44346   clinical trials with a EudraCT protocol, of which   7374   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    45 result(s) found for: Soft tissue injury. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2009-013864-37 Sponsor Protocol Number: 71231 Start Date*: 2010-02-05
    Sponsor Name:Gedeon Richter Plc.
    Full Title: A randomized, multicenter, double-blind, parallel study to compare the efficacy and safety profile of RGH-507 (tolperisone-containing) gel versus a ketoprofen-containing gel in the treatment of pat...
    Medical condition: acute soft tissue injury minor traumatism (such as: sprain, strain, dislocation,...etc.) or contusion
    Disease: Version SOC Term Classification Code Term Level
    12.0 10041291 Soft tissue injury PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2007-002653-23 Sponsor Protocol Number: 1/07 Start Date*: 2008-09-02
    Sponsor Name:The Police Rehabilitation Centre, Flint House
    Full Title: A pilot for a case control study to evaluate the effects of High Dosage Oxygen Therapy as an adjunct to an established program of physiotherapy and rehabilitation for sub acute soft tissue knee con...
    Medical condition: Sub acute soft tissue injuries to the knee .
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041292 Soft tissue injury NOS LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-005381-35 Sponsor Protocol Number: EP-DICLO/G-04-2012 Start Date*: 2013-06-20
    Sponsor Name:EPIFARMA SRL
    Full Title: Randomized, double-blind, placebo-controlled, parallel group, multi-centre clinical trial to evaluate safety and efficacy of Diclofenac 1% gel vs. placebo gel in patients with acute traumatic blunt...
    Medical condition: Patients with acute traumatic blunt soft tissue injury/contusion of the limbs.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004863 10041292 Soft tissue injury NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed) PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-018018-21 Sponsor Protocol Number: NL0910 Start Date*: 2010-06-09
    Sponsor Name:Reckitt Benckiser Healthcare UK
    Full Title: A randomised, double-blind, multi-centre, placebo controlled parallel group study to evaluate the efficacy and tolerability of a new Ibuprofen patch in patients with acute sports related traumatic ...
    Medical condition: Acute sports-related traumatic blunt soft tissue injury/contusion
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041738 Sports injury LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-018017-40 Sponsor Protocol Number: NL0919 Start Date*: 2010-06-09
    Sponsor Name:Reckitt Benckiser Healthcare UK Ltd
    Full Title: A randomised, double-blind, multi-centre, placebo controlled parallel group study to evaluate the efficacy and tolerability of a new Ibuprofen gel in patients with acute sports-related traumatic bl...
    Medical condition: Acute sports-related traumatic blunt soft tissue injury/contusion
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041738 Sports injury LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-004104-19 Sponsor Protocol Number: PH-L19TNFSARC-03/18 Start Date*: 2020-02-12
    Sponsor Name:Philogen S.p.A.
    Full Title: A randomized study to investigate the efficacy and safety of the tumor-targeting human antibody-cytokine fusion protein L19TNF in previously treated patients with advanced stage or metastatic soft-...
    Medical condition: Unresectable and/or metastatic soft-tissue sarcoma after failure of at least two prior systemic therapy regimens
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10075333 Soft tissue sarcoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Trial now transitioned) PL (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2016-005019-42 Sponsor Protocol Number: ET16-132 Start Date*: 2018-02-14
    Sponsor Name:Centre Léon Bérard
    Full Title: A European, multicenter, randomized, open-label, Phase II trial aiming to assess the clinical and biological activity of an anti-PD-L1 (atezolizumab) in operable localized soft tissue sarcomas pati...
    Medical condition: localised and operable soft tissue sarcomas
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10039491 Sarcoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2014-005574-11 Sponsor Protocol Number: Pennsaid-2014/P-3-01 Start Date*: 2015-06-18
    Sponsor Name:Nuvo Research GmbH
    Full Title: A randomized, double-blind, multi-center, placebo-controlled, parallel group study to evaluate the efficacy and safety of an Diclofenac 2% (w/w) cutaneous solution applied twice daily in patients w...
    Medical condition: Treatment of pain and Inflammation associated Acute Soft Tissue Injury/Ankle Sprain
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004863 10002549 Ankle sprain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-000888-26 Sponsor Protocol Number: DEV 1477-2 DIC 05 Start Date*: 2005-11-07
    Sponsor Name:ratiopharm GmbH
    Full Title: Randomised, double-blind, multi-centre, placebo-controlled clinical dose finding study in four parallel groups comparing Diclofenac Gel 1 %, Diclofenac Gel 3 %, Diclofenac Gel 5 % and placebo Gel i...
    Medical condition: Male or female ambulant patients (age range 18-60 years) suffering from fresh impact injuries (traumatic blunt soft tissue injury/contusion). Time elapse between traumatic event and inclusion must ...
    Disease: Version SOC Term Classification Code Term Level
    10022117 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002620-92 Sponsor Protocol Number: Pennsaid-C-2016/P-3-02 Start Date*: 2016-10-07
    Sponsor Name:Nuvo Pharmaceuticals Inc.
    Full Title: A multi-centre, randomised, controlled, double-blind, parallel-group study on the efficacy and safety of Pennsaid-2% topical skin solution in patients with Grade I-II ankle sprain
    Medical condition: Treatment of pain and Inflammation associated Acute Soft Tissue Injury/Ankle Sprain
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004863 10002549 Ankle sprain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-000909-22 Sponsor Protocol Number: MDS-KET-2004-01 Start Date*: 2004-08-27
    Sponsor Name:MDS Pharma Services
    Full Title: Comparative efficacy and tolerability of a topical ketoprofen TDS patch vs ketoprofen gel in the treatment of acute pain in soft-tissue injuries
    Medical condition: Acute pain in soft-tissue injuries of lower limbs, except toes
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-003257-29 Sponsor Protocol Number: NL1208 Start Date*: 2013-02-06
    Sponsor Name:Reckitt Benckiser Healthcare (UK)
    Full Title: A randomised, double-blind, multi-centre, placebo controlled parallel group study to evaluate the efficacy and tolerability of a new Ibuprofen patch in patients with acute sports related traumatic ...
    Medical condition: Acute sports-related traumatic blunt soft tissue injury/contusion to the upper or lower limbs
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004863 10031585 Other and unspecified injury to unspecified site LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-024641-71 Sponsor Protocol Number: 071(D)SC10102 Start Date*: 2011-05-12
    Sponsor Name:ANGELINI
    Full Title: A randomized, multicenter, double-blind study assessing the efficacy and safety of two topical 10% naproxen gel formulations in the treatment of benign soft-tissue injuries.
    Medical condition: Benign soft-tissue injuries.
    Disease: Version SOC Term Classification Code Term Level
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10028391 Musculoskeletal pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2021-003778-30 Sponsor Protocol Number: DRO-200/III/21/1 Start Date*: 2021-12-29
    Sponsor Name:Drossapharm AG
    Full Title: Randomized, controlled, multi-center trial to evaluate the efficacy and safety of Lixim 70 mg wirkstoffhaltiges Pflaster (etofenamate 70 mg medicated plaster) vs. placebo in the local symptomatic a...
    Medical condition: Acute strains, sprains or bruises of soft tissues following blunt trauma, e.g. sports injuries
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-020936-21 Sponsor Protocol Number: VOSG-P-319 Start Date*: Information not available in EudraCT
    Sponsor Name:Novartis Consumer Health S.A.
    Full Title: A randomized, double-blind, multi-center, placebo-controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel 1% applied four times daily in subjects with ...
    Medical condition: Acute blunt soft tissue injuries/contusions of the limbs
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050584 Contusion LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-004102-42 Sponsor Protocol Number: EP-DICLO/2G-01-2015 Start Date*: 2017-06-06
    Sponsor Name:Epifarma S.r.l.
    Full Title: Randomized, multi-center, double-blind, three-armed trial, to evaluate the non-inferiority, efficacy and safety of diclofenac2% gel (Test) versus the originator diclofenac2% gel chosen as Referenc...
    Medical condition: Acute traumatic events (injury/contusion) classified from mild to moderate pain at rest to the joints, muscles, tendons and ligaments
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10022117 Injury, poisoning and procedural complications SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing) LV (Completed) LT (Completed) HU (Ongoing) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-004343-92 Sponsor Protocol Number: 21559 Start Date*: 2021-06-23
    Sponsor Name:Bayer Healthcare LLC.
    Full Title: Randomized, Controlled, Double-blind, Placebo-controlled, Multi-center Hypothesis-finding Trial to Compare the Efficacy and Safety of a 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel and ...
    Medical condition: acute strains, sprains or bruises of the lower extremities following blunt trauma
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2020-005217-41 Sponsor Protocol Number: 51-03FPAEU Start Date*: 2021-09-06
    Sponsor Name:Lead Chemical Company Ltd
    Full Title: Randomized, controlled, multi-center trial to evaluate the efficacy and safety of a Flurbiprofen 40 mg cutaneous hydrogel medicated plaster vs. placebo and vs. a marketed active comparator in the l...
    Medical condition: pain in acute strains, sprains or bruises of the soft tissues following blunt trauma, e.g. sports injuries
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-001038-32 Sponsor Protocol Number: 48-03LXPU Start Date*: 2019-10-15
    Sponsor Name:Lead Chemical Company Ltd
    Full Title: Randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a Loxoprofen sodium 60 mg tape medicated plaster vs. placebo in the local symptomatic and short-term ...
    Medical condition: Acute blunt, soft tissue injuries of the limbs
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004863 10041775 Sprains and strains of ankle and foot LLT
    20.0 100000004863 10032894 Other specified sites of sprains and strains LLT
    20.0 100000004863 10041777 Sprains and strains of elbow and forearm LLT
    20.0 100000004863 10041790 Sprains and strains of shoulder and upper arm LLT
    20.0 100000004863 10041798 Sprains and strains of wrist and hand LLT
    21.0 100000004866 10019428 Hematoma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2020-003543-29 Sponsor Protocol Number: 48-04LXPU Start Date*: 2021-05-07
    Sponsor Name:Lead Chemical Company Ltd.
    Full Title: Randomized, controlled, multi-center trial to evaluate the efficacy and safety of a Loxoprofen sodium 60 mg medicated plaster vs. placebo and vs. a marketed comparator in the local symptomatic and ...
    Medical condition: Acute blunt, soft tissue injuries of the muscles or limbs
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Jun 27 15:31:23 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA